TRDA up 9%. What's going on:

Entrada Therapeutics Inc (TRDA) is trading 9% higher at $12.93 today. The stock is outperforming peers in a generally "meh" day in the healthcare sector.

There was no clear catalyst for why the stock was moving higher, but about a month ago SEC filings show that a large hedge fund had purchased shares in the company. Maybe somebody knows something we don't?

Entrada Therapeutics Inc has been trading between a 52-week high of $36.85 and a 52-week low of $5.12. The stock has a market cap of $406 Million.